Trial

NC003 Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis With Clofazimine (C)-TMC207 (J)-PA-824 (Pa)-Pyrazinamide (Z)

Study Director
Start Date
10 / 2012
Trial Phase
Trial Status
enrolling
Current Enrollment
Target Enrollment
105
Overview
Compound Associations
Pretomanid (PA-824) in combination with bedaquiline, moxifloxacin, pyrazinamide, and linezolid